SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001262463-22-000024
Filing Date
2022-02-03
Accepted
2022-02-03 17:27:01
Documents
41
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gwhp12312110q.htm   iXBRL 10-Q 572606
2 EXHIBIT 31.1 ex311.htm EX-31 10106
3 EXHIBIT 32.1 ex321.htm EX-32 4872
  Complete submission text file 0001262463-22-000024.txt   3092725

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gwhp-20211231.xsd EX-101.SCH 27961
5 XBRL CALCULATION FILE gwhp-20211231_cal.xml EX-101.CAL 36152
6 XBRL DEFINITION FILE gwhp-20211231_def.xml EX-101.DEF 93005
7 XBRL LABEL FILE gwhp-20211231_lab.xml EX-101.LAB 216290
8 XBRL PRESENTATION FILE gwhp-20211231_pre.xml EX-101.PRE 172904
35 EXTRACTED XBRL INSTANCE DOCUMENT gwhp12312110q_htm.xml XML 372859
Mailing Address 1130 CALLE CORDILLERA SAN CLEMENTE CA 92673
Business Address 1130 CALLE CORDILLERA SAN CLEMENTE CA 92673 (714) 392-4112
Global Wholehealth Partners Corp (Filer) CIK: 0001598308 (see all company filings)

IRS No.: 462316220 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-56035 | Film No.: 22589815
SIC: 2835 In Vitro & In Vivo Diagnostic Substances